Related Experiment Video
Updated: Jun 12, 2025
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
9.6K
Repurposing Drugs for Cancer Prevention: Targeting Mechanisms Common to Chronic Diseases
1From the Medical Oncology Service, Center for Cancer Research, National Cancer Institute, National Institutes of Health.
Cancer Journal (Sudbury, Mass.)
|September 23, 2024
Summary
Developing cancer prevention strategies requires balancing safety and effectiveness. Targeting shared risk factors for multiple cancers and chronic diseases like obesity offers a promising approach for comprehensive health interventions.
Area of Science:
- Oncology
- Preventive Medicine
- Chronic Disease Management
Background:
- Cancer prevention agent development is complex, balancing safety and efficacy.
- Individuals at high risk for cancer often face risks for multiple cancers and chronic diseases.
- Aging increases the risk for various cancers and chronic conditions.
Purpose of the Study:
- To explore the potential for combined targeting of cancer and other chronic diseases.
- To identify shared mechanisms underlying various cancers and age-related diseases.
- To discuss examples of overlapping pathogenesis.
Main Methods:
- Review of existing literature on shared risk factors.
- Analysis of commonalities in pathogenesis between cancers and chronic diseases.
- Identification of potential targets for combined interventions.
Main Results:
- Shared environmental exposures, genetic predispositions, and metabolic factors link cancers and chronic diseases.
- Obesity, diabetes, and cardiovascular disease share common pathogenic mechanisms with various cancers.
- These overlaps suggest opportunities for integrated prevention strategies.
Conclusions:
- Combined targeting of cancer and chronic diseases is a viable strategy.
- Understanding shared mechanisms can lead to more effective prevention agents.
- Integrated approaches may improve outcomes for individuals at risk for multiple conditions.
More Related Videos
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
8.7K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
Related Concept Videos
02:59Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:26Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
02:18Cancer
48.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.2K